24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Medical Disorders
Resources
Basic InformationLookupsLatest News
Don't Want a 2nd Heart Attack? Lose the Belly FatHow to Keep Those Blood Vessels PumpingScreening for Chinese Coronavirus to Start at 3 Major Airports: CDCDo You Take Warfarin? Time of Day Might Not MatterHealth Tip: Signs of Food PoisoningSepsis Causes Far More Deaths Worldwide Than ThoughtMillennials Most Likely to Skip Flu Shot, Believe 'Anti-Vaxxer' Claims: PollResearchers Alter Mosquitoes to Resist Dengue InfectionMany Americans Are Inactive, With Southerners Faring WorseVirtual Reality Can Bring Real-Life PainAre Doctors Discarding 'Injured' Kidneys That Might Be Used for Transplant?Nerve Stimulation Therapy Could Cut Fibromyalgia PainWhich Obesity Surgery Is Right for You?Brake Dust Another Driver of Air PollutionWhat Works Best to Help Men With Overactive Bladder?More Studies Link Vaping to Asthma, COPDCertain Diabetes Meds May Lower Gout Risk, TooHeart Transplants From Donors With Hepatitis C May Be Safe: StudyClimate Change May Translate Into More Fatal InjuriesAll in the Timing: Many Get Knee Replacement Too Late or Too SoonHealth Tip: Preparing for an UltrasoundLow Levels of Key Blood Cells Could Signal Higher Death RiskGyms Are Fertile Ground for GermsTwo More Heartburn Meds Recalled Due to Possible CarcinogenZika Damage Showing Up in Babies Deemed 'Normal' at BirthHealth Tip: Coping With Winter NosebleedsHeart Disease May Up Risk of Kidney FailureFlu Cases Surge Early, Could a Tough Season Lie Ahead?Cluster of Unhealthy Risk Factors Could Raise Odds of Recurrent Blood ClotsAHA News: Worried About Dementia? Check This Blood Pressure NumberNew Study Reports Alarming Surge in E-Scooter AccidentsSo Long, 98.6: Average Human Body Temperature Is DroppingWhat Matters More for Obesity Risk, Genes or Lifestyle?Health Tip: Protect Yourself From Household ChemicalsOzone, Wood Smoke Raise Odds of COPD in Smokers and NonsmokersSmog May Be Bad for Your BonesEver Get a Rash from Your Skin Cream or Makeup? Here's WhyHealth Tip: 5 Eye Myths DebunkedHealth Tip: Allergic Reaction First AidTB Vaccine More Powerful When Given IntravenouslyGene Therapy May Be Long-Term Cure for Type of HemophiliaClots in Space: Astronaut's Blocked Vein Brings Medical InsightHealth Tip: Help Your Child Safely Lose WeightPatients Often Bring Undetected 'Superbug' to the Hospital: StudyExperimental Drug Could Be New Option Against ArthritisBanned for Decades, DDT and Dioxins Are Still Harming U.S. BabiesHealth Tip: When Bruising is a Red FlagAmericans Need to Tackle Youth Obesity: U.S. Task ForceFestive Foods Can Leave Those on Restricted Diets Out in the ColdHow You Can Be Overfat Without Being Overweight
Questions and AnswersLinks
Related Topics

Diabetes

3 Drugs for Severe Epileptic Seizures Are Equally Effective: Study

HealthDay News
by -- Robert Preidt
Updated: Dec 5th 2019

new article illustration

THURSDAY, Dec. 5, 2019 (HealthDay News) -- Three drugs used to treat severe seizures in epilepsy patients are equally effective, a new study finds.

The three medications -- levetiracetam (Keppra and Roweepra), fosphenytoin (Cerebyx) and valproate -- are commonly used to treat patients with "refractory status epilepticus." In these patients, severe seizures continue after treatment with benzodiazepine medications.

The study of 380 emergency department patients compared the three drugs' effectiveness in stopping seizures and improving patients' levels of responsiveness within 60 minutes. The patients included children and adults.

The three treatments stopped seizures and improved responsiveness in about half of the patients: 47% in the levetiracetam group; 45% in the fosphenytoin group; and 46% in the valproate group. Researchers said the differences were not statistically significant.

The three drugs had no differences in serious side effects, according to the study published Nov. 28 in the New England Journal of Medicine.

The research was supported by the U.S. National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health.

"Doctors can be confident that the particular treatment they choose for their patients with status epilepticus is safe and effective, and may help them avoid the need to intubate the patient as well as stays in the intensive care unit," study co-author Dr. Robin Conwit, NINDS program director, said in an agency news release.

Study co-leader Dr. Robert Silbergleit said the study suggests that clinical outcomes are driven by factors other than drugs.

"Differences in how doctors decide to treat status epilepticus, such as when they give more drugs or when to anesthetize patients and put them on a mechanical ventilator, may be more important than the specific treatments used to control seizures in patients," said Silbergleit, a professor of emergency medicine at the University of Michigan in Ann Arbor.

In status epilepticus, seizures occur close together and last more than 5 minutes, with a loss of consciousness. If not treated, patients can suffer severe brain damage or die. Benzodiazepines are effective in two-thirds of patients.

More information

The American Academy of Family Physicians has more on epilepsy.